“Insurance-linked securities (ILS) are a type of financial instrument that allows investors to participate in the insurance market and earn returns based on the occurrence or non-occurrence of certain events, such as natural disasters, pandemics, or mortality changes. Hence, ILS can be seen as a way of turning risk into value, as they provide benefits for both the issuers and the investors of these securities.
There are different types of ILS, depending on the nature of the risk transferred, the structure of the transaction, and the legal form of the instrument. Some of the common types of ILS are:
(i) Catastrophe bonds (cat bonds): These are bonds issued by insurance or reinsurance companies and are linked to specific natural disasters such as earthquakes, hurricanes, and typhoons. The investors receive periodic coupons from the issuer, but they may lose part or all of their principal if a predefined trigger event occurs during the bond’s term. Cat bonds are the most prevalent type of ILS in the market.
(ii) Insurance-linked swaps: These are derivatives contracts that transfer insurance risk from one party to another, typically with the aid of a third party such as an investment bank. The parties agree to exchange periodic payments based on the occurrence or non-occurrence of certain events, such as mortality changes, pandemics, or credit defaults. Insurance-linked swaps can be customized to suit the needs and preferences of the parties involved.
(iii) Embedded value securitization: This is a type of securitization that involves the sale of future profits from a portfolio of life insurance policies to investors. The issuer transfers the risk and reward of managing the policies to the investors, who receive periodic payments based on the actual performance of the portfolio. Embedded value securitization can help life insurers free up capital and optimize their balance sheets.
(iv) Extreme mortality securitization: This is a type of securitization that involves the transfer of mortality risk from an insurer or reinsurer to investors. The issuer pays a fixed amount to the investors, who in turn pay a variable amount based on the actual mortality experience of a reference population. Extreme mortality securitization can help insurers and reinsurers hedge against large losses due to pandemics, wars, or terrorist attacks.
(v) Life settlements securitization: This is a type of securitization that involves the purchase and resale of life insurance policies from policyholders who no longer need or want them. The issuer buys the policies at a discount and pays the premiums until the death of the insured. The issuer then sells securities backed by the expected death benefits to investors, who receive periodic payments based on the actual mortality experience of the underlying policies. Life settlements securitization can provide liquidity and diversification for both policyholders and investors.
(vi) Longevity swaps: These are derivatives contracts that transfer longevity risk from one party to another, usually from a pension fund or an annuity provider to an insurer or reinsurer. The parties agree to exchange periodic payments based on the actual survival rates of a reference population. Longevity swaps can help pension funds and annuity providers hedge against the risk of increasing life expectancy and rising pension liabilities.
(vii) Reserve funding securitization: This is a type of securitization that involves the transfer of reserve risk from an insurer or reinsurer to investors. The issuer pays a fixed amount to the investors, who in turn pay a variable amount based on the actual development of claims reserves for a specified line of business. Reserve funding securitization can help insurers and reinsurers reduce their capital requirements and improve their solvency ratios.
Accounting treatment of ILS under IFRS is not straightforward, as it depends on the agreed terms and conditions of each transaction and the nature of the underlying risk transferred. Therefore, it is essential to assess the substance and economic reality of each ILS contract and apply the appropriate accounting standards and policies.
Also, to be eligible as a risk mitigation technique under Solvency II, ILS must meet certain requirements regarding their effectiveness, enforceability, documentation, disclosure, valuation, and recognition. These requirements aim to ensure that the risk transfer is genuine and verifiable, and that the capital relief is commensurate with the risk reduction achieved. For example, some of the requirements are that the ILS contract must be legally binding and irrevocable, that the credit quality of the counterparty must be taken into account, and that the risk transfer must be fully reflected in the technical provisions and solvency capital requirement calculations. Therefore, it is advisable to consult with experts and regulators before issuing or investing in ILS, as well as to monitor and review the performance and compliance of these instruments on a regular basis. ILS can offer significant benefits for both insurers and investors, but they also entail complex and evolving risks that need to be properly understood and managed.
As always, the devil is in the details!”